Trade Names:
Status: Approved
Entry Type: Protein
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Diabetes Mellitus; Diabetes Mellitus, Type 1 Phase 1 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 1 Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 1 Phase 3 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Investigations
16.5
Injury, poisoning and procedural complications
12.36
General disorders and administration site conditions
10.07
Nervous system disorders
9.74
Eye disorders
6.21
Vascular disorders
5.65
Metabolism and nutrition disorders
5.27
Musculoskeletal and connective tissue disorders
4.03
Endocrine disorders
3.96
Psychiatric disorders
3.58
Cardiac disorders
3.46
Skin and subcutaneous tissue disorders
3.2
Gastrointestinal disorders
2.9
Respiratory, thoracic and mediastinal disorders
2.58
Infections and infestations
2.48